Asarina Pharma AB (publ) (ASAP.ST)

SEK 0.03

(-31.03%)

Long Term Debt Summary of Asarina Pharma AB (publ)

  • Asarina Pharma AB (publ)'s latest annual long term debt in 2023 was 1 Million SEK , down 0.0% from previous year.
  • Asarina Pharma AB (publ)'s latest quarterly long term debt in 2023 FY was 1 Million SEK , down 0.0% from previous quarter.
  • Asarina Pharma AB (publ) reported annual long term debt of - SEK in 2022, down 0.0% from previous year.
  • Asarina Pharma AB (publ) reported annual long term debt of - SEK in 2021, down 0.0% from previous year.
  • Asarina Pharma AB (publ) reported quarterly long term debt of - SEK for 2023 Q2, down 0.0% from previous quarter.
  • Asarina Pharma AB (publ) reported quarterly long term debt of - SEK for 2023 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Asarina Pharma AB (publ) (2023 - 2017)

Historical Annual Long Term Debt of Asarina Pharma AB (publ) (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 1 Million SEK 0.0%
2022 - SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%

Peer Long Term Debt Comparison of Asarina Pharma AB (publ)

Name Long Term Debt Long Term Debt Difference
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.894%
AcouSort AB (publ) - SEK -Infinity%
Active Biotech AB (publ) 3 Million SEK 66.667%
Alzinova AB (publ) 800 Thousand SEK -25.0%
Amniotics AB (publ) - SEK -Infinity%
BioArctic AB (publ) 2.15 Million SEK 53.532%
Camurus AB (publ) 13.61 Million SEK 92.654%
Cantargia AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Genovis AB (publ.) 74.8 Million SEK 98.663%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -17.647%
Kancera AB (publ) - SEK -Infinity%
Karolinska Development AB (publ) - SEK -Infinity%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 43.214%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 96.931%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 98.467%
Simris Alg AB (publ) 90.74 Million SEK 98.898%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 99.114%
Xintela AB (publ) - SEK -Infinity%
Ziccum AB (publ) 286 Thousand SEK -249.65%
Isofol Medical AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 96.87%
CombiGene AB (publ) - SEK -Infinity%
Diamyd Medical AB (publ) 30.67 Million SEK 96.74%
Intervacc AB (publ) 142 Thousand SEK -604.225%
Alligator Bioscience AB (publ) 7.51 Million SEK 86.695%
Sprint Bioscience AB (publ) - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 95.92%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 76.723%
Spago Nanomedical AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -135.849%
Egetis Therapeutics AB (publ) 103.4 Million SEK 99.033%
2cureX AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.882%
Cyxone AB (publ) 74 Thousand SEK -1251.351%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 30.362%
Biosergen AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -635.294%
SynAct Pharma AB 58 Thousand SEK -1624.138%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 14.53 Million SEK 93.12%
Stayble Therapeutics AB (publ) 850 Thousand SEK -17.647%
Oncopeptides AB (publ) 106.48 Million SEK 99.061%
Pila Pharma AB (publ) - SEK -Infinity%
Ascelia Pharma AB (publ) 176 Thousand SEK -468.182%
Diagonal Bio AB (publ) - SEK -Infinity%